Does ELTROMBOPAG OLAMINE Cause Therapy non-responder? 183 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 183 reports of Therapy non-responder have been filed in association with ELTROMBOPAG OLAMINE (ELTROMBOPAG). This represents 1.1% of all adverse event reports for ELTROMBOPAG OLAMINE.
183
Reports of Therapy non-responder with ELTROMBOPAG OLAMINE
1.1%
of all ELTROMBOPAG OLAMINE reports
33
Deaths
49
Hospitalizations
How Dangerous Is Therapy non-responder From ELTROMBOPAG OLAMINE?
Of the 183 reports, 33 (18.0%) resulted in death, 49 (26.8%) required hospitalization, and 17 (9.3%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG OLAMINE. However, 183 reports have been filed with the FAERS database.
What Other Side Effects Does ELTROMBOPAG OLAMINE Cause?
Platelet count decreased (3,419)
Death (2,797)
Drug ineffective (1,117)
Platelet count increased (980)
Fatigue (868)
Headache (750)
Nausea (584)
Diarrhoea (558)
Product use in unapproved indication (545)
Malaise (516)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which ELTROMBOPAG OLAMINE Alternatives Have Lower Therapy non-responder Risk?
ELTROMBOPAG OLAMINE vs ELUXADOLINE
ELTROMBOPAG OLAMINE vs ELVITEGRAVIR
ELTROMBOPAG OLAMINE vs EMAPALUMAB
ELTROMBOPAG OLAMINE vs EMAPALUMAB-LZSG
ELTROMBOPAG OLAMINE vs EMEND